©The Author(s) 2025.
World J Psychiatry. Oct 19, 2025; 15(10): 106312
Published online Oct 19, 2025. doi: 10.5498/wjp.v15.i10.106312
Published online Oct 19, 2025. doi: 10.5498/wjp.v15.i10.106312
Table 4 Social functioning assessment, mean ± SD
| Indicator | Intervention group (n = 60) | Control group (n = 60) | P value |
| Mean total SDSS score at baseline | 7.2 ± 1.8 | 7.1 ± 1.9 | 0.81 |
| Mean total SDSS score at 12 months | 2.8 ± 1.1 | 4.5 ± 1.4 | < 0.001 |
| Reduction in total SDSS score | 4.4 ± 1.5 | 2.6 ± 1.3 | < 0.001 |
| Percentage of patients with improved social engagement (%) | 82 | 55 | < 0.001 |
| Social activities score | 3.0 ± 1.0 | 5.0 ± 1.2 | < 0.001 |
| Interpersonal relationships score | 2.5 ± 1.0 | 4.0 ± 1.3 | < 0.001 |
| Work performance score | 2.8 ± 1.1 | 4.2 ± 1.4 | < 0.001 |
| Family life score | 2.7 ± 1.0 | 4.0 ± 1.2 | < 0.001 |
| Additional indicators | |||
| PMHS-C | 3.5 ± 0.5 | 2.8 ± 0.6 | < 0.001 |
| Social support score | 8.0 ± 1.5 | 6.5 ± 1.8 | < 0.001 |
| Community participation score | 7.5 ± 1.2 | 5.8 ± 1.5 | < 0.001 |
| Psychological resilience score | 8.2 ± 1.3 | 6.8 ± 1.6 | < 0.001 |
- Citation: Meng YB, Ma YH, Yang Y, Li DD, Zhang RX, Ren CM. Continuous treatment strategies improve psychological status and quality of life in patients with atopic dermatitis. World J Psychiatry 2025; 15(10): 106312
- URL: https://www.wjgnet.com/2220-3206/full/v15/i10/106312.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i10.106312